Homologous Recombination Pathway Alternation Predicts Prognosis of Colorectal Cancer With Chemotherapy

• Ngā kaituhi matua: Yan Lin (Author), Xiaoli Liao (Author), Yumei Zhang (Author), Guobin Wu (Author), Jiazhou Ye (Author), Shanshan Luo (Author), Xinxin He (Author), Min Luo (Author), Mingzhi Xie (Author), Jinyan Zhang (Author), Qian Li (Author), Yu Huang (Author), Sina Liao (Author), Yongqiang Li (Author), Rong Liang (Author)
• Hōputu: Pukapuka
• I whakaputaina: Frontiers Media S.A., 2022-06-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Background: Chemotherapy is the basic treatment for colorectal cancer (CRC). However, colorectal cancer cells often develop resistance to chemotherapy drugs, leading to recurrence and poor prognosis. More and more studies have shown that the Homologous recombination (HR) pathway plays an important r...